News & Blog

Tag Archives: Treatment

Can Newly Approved “Tissue Agnostic” Drugs Benefit Pediatric High-grade Glioma Patients?

Recently, the U.S. Food and Drug Administration (FDA) granted accelerated approval* to the drug Rozlytrek (entrectinib, Genentech/Roche**) as a treatment for patients, 12 years or older, whose tumors have a specific genetic defect known as an “NTRK gene fusion.”*** This is now the second drug that the FDA has approved to treat patients with this […]

Fundraising Gets Personal for Two-Time Meningioma Survivor

The First One: 2012 “It happened really, really quickly,” says Sharon Mottola of when she was first diagnosed with a meningioma brain tumor in 2012. Sharon, a registered nurse working at a North Carolina healthcare facility, had been experiencing chronic déjà vu for some time and decided to use her proximity to her primary care […]

A Missing Link to Glioblastoma Growth?

An enzyme that serves as a link between oncogenes and the lipids that make-up cells’ membranes may be an important new drug target to treat glioblastoma and other tumors Glioblastoma, like all cancers, develops and progresses as cells begin to multiply and grow out of control, forming a tumor.  Mutations to a protein known as […]

Share